is a nucleic acid amplification test for paediatric pulmonary tuberculosis (TB). Culture is an inadequate reference standard owing to its poor sensitivity, 1 so the accuracy of Xpert is often evaluated by comparing it to a composite reference standard based on multiple imperfect tests. 2 3 Table 1 shows a composite reference standard defined using data gathered in a South African cohort study of symptomatic children. 6 It classifies a child who is positive on culture, smear microscopy, chest radiography, or the tuberculin skin test as having TB. The apparent advantage of this composite reference standard is that it would identify more TB cases than culture alone. Studies using a standard such as this typically treat it as an error-free reference test to estimate the new test's sensitivity (proportion of all patients with the disease that are correctly detected by the new test) and specificity (proportion of all patients without the disease who are correctly detected by the new test). 3 7 Ensuring the new test is not used to define the composite reference standard is thought to protect against overestimating the new test's accuracy. 8 Composite reference standards are used for diverse conditions including Chlamydia trachomatis infection, apathy, and prostate cancer (see web table 1). Some are required by regulatory authorities for approval of new tests. 9 Despite their widespread use, the number of tests necessary to define an adequate standard is unknown. Composite reference standards based on two or three tests are most common, 7 10 but some are based on upwards of eight or nine tests (web table 1). 2 11 Consequences of both the composite reference standard and the new test making the same errors are also not well understood. We discuss previously ignored concerns related to composite reference standards using numerical examples and data from a study of childhood TB and draw attention to better methods. We focus on composite reference standards based on the OR rule, which classifies patients with at least one positive test as disease positive and those with all negative tests as disease negative. 3 Other possible composite rules include the AND rule, 
numerical examples
In these examples, the sensitivities of the component tests used to define the composite reference standard are moderate to high and their specificities are near perfect. An OR rule composite reference standard is, therefore, anticipated to have higher sensitivity than a single imperfect reference test. We generated data for a sample of 1000 people assuming the composite reference standard was made up of component tests with sensitivity of 70% and specificities of 98-100% (detailed explanation in the web appendix). Disease prevalence was assumed to be 10%-that is, 100 patients were disease positive and 900 were disease negative. The new test under evaluation was set to have a sensitivity of 90% and a specificity of 98%.
Increasing the number of component tests Misclassification of disease status
Depending on their accuracy, adding more component tests to the composite reference standard might cause more misclassification rather than less. We start with the ideal situation where each component test has perfect specificity of 100% and where the different component tests are conditionally independent (meaning that they are not prone to making the same false positive or false negative errors). Table 2 lists the frequency of results on the component tests and the composite reference standards based on them. As we move from a single reference test to a composite reference standard based on two or three component tests, the number of patients correctly classified as having the disease increases from 70 (34+15+15+6) to 91 (34+15+15+6+15+6) to 97 (34+15+15+6+15+6+6). The gain at the second step is less than at the first. After about five component tests (data not shown), additional tests increase costs but don't result in any gain, as all 1000 patients are correctly identified. Table 2 shows how misclassification changes when the specificity of the component tests decreases to 98%. The classification of disease positive patients remains the same, but the number of misclassified disease negative patients increases from 17 to 51 as we move from a single reference test to a composite reference standard with three component tests. For this example, the composite reference standard with three component tests resulted in more misclassified patients overall (three false positives and 51 false negatives) than the single reference test (30 false positives and 17 false negatives). The overall number of misclassified patients will continue to rise as more component tests are added to the composite reference standard. 12 
Sensitivity and specificity of new tests
Using the data in table 2 we can show that when all component tests have perfect specificity and are conditionally independent, the sensitivity of the new test is estimated accurately at its value of 90% irrespective of the number of tests in the composite reference standard (fig 1a) . The estimate of the specificity of the new test steadily improves with every added test until it reaches the true value (fig 1b) . When the specificity of the component tests falls to 98%, the specificity estimates of the new test are almost identical to those obtained previously, but the sensitivity of the new test is now underestimated (fig 1) . When the composite reference standard was composed of three tests, for example, the estimated sensitivity was 59%, much lower than the true value of 90%. This underestimation worsens with every test added to the composite reference standard.
Overestimating sensitivity or specificity of the new test So far, we have assumed that all tests-component tests in the composite reference standard and the new testare conditionally independent. In practice, however, errors made by multiple tests might be correlated. 13 In studies evaluating new tests for Chlamydia trachomatis, for example, the component tests and the new test are typically nucleic acid amplification tests, which risk making the same false positive error of detecting a non-viable organism.
14 In these situations, the composite reference standard can overestimate the accuracy of the new test because it does not adjust for the presence of conditional dependence-that is, the errors of the new test remain undetected.
To study the effects of conditional dependence, we generated data from a setting where both tests are likely to make the same false positive errors even though their specificity remains high at 98% (see web table 2 for details). 6 As in our previous example, the sensitivity of the new test is underestimated, and this worsens with each component test added to the composite reference standard (fig 1) . The specificity of the new test is underestimated when compared to a single imperfect test but becomes overestimated as component tests are added to the composite reference standard (fig 1) . As the number of component tests increases, the estimated specificity of the new test converges to a value higher than the true value. 12 In our example, the new test's specificity will converge at 99.94%, compared with its true specificity of 98%. This may not seem like a large magnitude of bias but could lead to an important underestimate of the number of false positives the new test will produce in a low prevalence population. Comparability across studies When a new test is compared to the same composite reference standard in two different studies, the reported value of the new test's accuracy will depend on the disease prevalence in each study. Using a standardised composite reference standard therefore does not ensure comparability across studies. We considered a composite reference standard based on three conditionally independent component tests, each with sensitivity 70% and specificity 98%. Disease prevalence ranged from low (5%) to high (30%), as might be expected across geographic regions or healthcare settings. The new test's sensitivity was assumed to be 90% and its specificity 98%, as before. We found the estimated sensitivity of the new test ranged from 43% when the prevalence was 5% to 79% when the prevalence is 30% (web figure 1) . Estimated specificity did not vary greatly with prevalence for the settings we used.
Latent class models can make better use of data
The drawbacks of the composite reference standard can be overcome using a statistical modelling approach called latent class analysis. 3 Instead of classifying subjects into fixed disease categories, latent class analysis estimates the probability that each patient has the disease using all observed tests, including the test under evaluation (web figure 2) . It adjusts for the sensitivity and specificity of each test as well as the possibility of conditional dependence between them. Simply put, latent class analysis considers how certain we are about classifying patients into diseased or nondiseased groups rather than making a black and white decision. Column 8 of table 1 shows the estimated risk of TB for each observed combination of tests based on a recent latent class analysis for the childhood TB data. 6 Notably, the estimated risk of TB from this latent class analysis follows the gradation proposed by an expert group's clinical case definition (column 9 of table 1), 4 which classifies subjects into confirmed TB, probable TB, possible TB, and unlikely TB groups, using the same four tests as the composite reference standard. Our data show that composite reference standard would classify confirmed, probable and possible TB cases all as having TB, resulting in an estimated prevalence of 94%. Using culture as a reference would only consider the confirmed TB cases, resulting in an underestimate of the prevalence (16.4%). Latent class analysis estimates a 100% risk of TB for most cases of confirmed TB, though the risk is lower for unusual patterns. The risk of TB among the probable and possible TB cases ranges from 9% to 52% among patients with a negative Xpert test but increases when Xpert is positive. The resulting prevalence estimate based on latent class analysis is 26.7%. Because the latent class analysis adjusts for conditional dependence between culture and Xpert, it also provides a more realistic estimate of Xpert sensitivity (49.4%) than would be obtained with culture (74.4%) or the composite reference standard (22.5%) (see web material for how the latent class analysis estimates were calculated).
The advantages of latent class analysis are accompanied by the challenges of using a more sophisticated analytical technique. Construction of these models requires interdisciplinary expertise of both methodologists and clinicians 6 to determine the particular tests, covariates, conditional dependence structure, and previous knowledge to be considered.
Validation of these models against a perfect reference may not always be possible. Sometimes competing models cannot be distinguished using standard statistical methods. 15 This is not a drawback of latent class analysis, but a reflection of the uncertainty in our knowledge due to the lack of a perfect reference test. Composite reference standards may be considered clinically meaningful 17 as they resemble clinical decision rules, which classify patients into mutually exclusive categories to support decision makingfor example, rules identifying whether a subject is a candidate for TB treatment. Such decision rules are not necessary in research settings as no black or white decision needs to be made. Clinical decision rules might indicate the best possible management strategy, but are recognised by clinicians as imperfect. 16 Yet similar rules are used to define composite reference standards for a diagnostic accuracy studies with no such recognition.
In the absence of a perfect reference test, a new test could be evaluated in terms of outcomes such as diagnostic yield or effect on patient management instead of accuracy. 18 Latent class analysis would also be relevant in such analyses to estimate percentage of overdiagnosis or overtreatment, 6 19 eventually supporting the development of optimal clinical decision rules. As our ability to measure results on multiple tests/ biomarkers increases, development of appropriate latent class models should be pursued in the absence of a perfect reference test to make optimal use of the data gathered.
Linked information
• More detail on the problems with composite reference standards https://www.ncbi.nlm.nih.gov/ pubmed/26555849 
